VX17-661-116


Study NameStudy TitleStudy TypeSponsorSponsor Type
VX17-661-116A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Tezacaftor in Combination With Ivacaftor in Subjects With Cystic Fibrosis Aged 6 Years and Older, Homozygous or Heterozygous for the F508del-CFTR MutationClinical TrialVertexIndustry Sponsored